{"id":"https://openalex.org/W2116239162","doi":"https://doi.org/10.1161/hypertensionaha.111.171074","title":"Participation in a Clinical Trial Enhances Adherence and Persistence to Treatment: A Retrospective Cohort Study","display_name":"Participation in a Clinical Trial Enhances Adherence and Persistence to Treatment: A Retrospective Cohort Study","alternate_titles":[],"publication_year":2011,"publication_date":"2011-08-09","ids":{"openalex":"https://openalex.org/W2116239162","doi":"https://doi.org/10.1161/hypertensionaha.111.171074","mag":"2116239162","pmid":"https://pubmed.ncbi.nlm.nih.gov/21825228"},"language":"en","primary_location":{"id":"doi:10.1161/hypertensionaha.111.171074","doi":"https://doi.org/10.1161/hypertensionaha.111.171074","is_oa":true,"landing_page_url":"https://doi.org/10.1161/hypertensionaha.111.171074","pdf_url":"https://www.ahajournals.org/doi/pdf/10.1161/HYPERTENSIONAHA.111.171074","source":{"id":"https://openalex.org/S67880631","display_name":"Hypertension","issn_l":"0194-911X","issn":["0194-911X","1524-4563"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hypertension","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2116239162"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.ahajournals.org/doi/pdf/10.1161/HYPERTENSIONAHA.111.171074","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049645213","display_name":"Hein A. W. van Onzenoort","orcid":"https://orcid.org/0000-0002-3272-2898","observed_orcids":["https://orcid.org/0000-0002-3272-2898"]},"institutions":[{"id":"https://openalex.org/I2800191616","display_name":"Maastricht University Medical Centre","ror":"https://ror.org/02d9ce178","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2800191616"]},{"id":"https://openalex.org/I2802934949","display_name":"Radboud University Medical Center","ror":"https://ror.org/05wg1m734","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802934949"]},{"id":"https://openalex.org/I34352273","display_name":"Maastricht University","ror":"https://ror.org/02jz4aj89","country_code":"NL","type":"education","lineage":["https://openalex.org/I34352273"]},{"id":"https://openalex.org/I4210133559","display_name":"Zuyderland Medisch Centrum","ror":"https://ror.org/03bfc4534","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210133559","https://openalex.org/I4210166163"]}],"countries":["NL"],"is_corresponding":true,"raw_author_name":"Hein A.W. van Onzenoort","raw_affiliation_strings":["From the Department of Clinical Pharmacy (H.A.W.O.), Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands; Utrecht Institute for Pharmaceutical Sciences (F.E.M.), Division of Pharmacoepidemiology and Pharmacotherapy, Utrecht, the Netherlands, Department of Clinical Pharmacy and Toxicology (C.N.), University Hospital Maastricht, Maastricht, the Netherlands; Cardiovascular Research Institute Maastricht (C.N., A.A.K., P.W.d.L.), Maastricht University and Department of Internal Medicine","Cardiovascular Research Institute Maastricht (C.N., A.A.K., P.W.d.L.), Maastricht University and Department of Internal Medicine, University Hospital Maastricht, Maastricht, the Netherlands","Department of Clinical Pharmacy (P.-H.M.v.d.K.), Orbis Medical Centre, Sittard, the Netherlands","Hein A.W. van Onzenoort From the Department of Clinical Pharmacy (H.A.W.O.), Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands","Microlife Corporation (W.J.V.), Taipei, Taiwan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Clinical Pharmacy (H.A.W.O.), Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands; Utrecht Institute for Pharmaceutical Sciences (F.E.M.), Division of Pharmacoepidemiology and Pharmacotherapy, Utrecht, the Netherlands, Department of Clinical Pharmacy and Toxicology (C.N.), University Hospital Maastricht, Maastricht, the Netherlands; Cardiovascular Research Institute Maastricht (C.N., A.A.K., P.W.d.L.), Maastricht University and Department of Internal Medicine","institution_ids":["https://openalex.org/I2800191616","https://openalex.org/I2802934949","https://openalex.org/I34352273"]},{"raw_affiliation_string":"Cardiovascular Research Institute Maastricht (C.N., A.A.K., P.W.d.L.), Maastricht University and Department of Internal Medicine, University Hospital Maastricht, Maastricht, the Netherlands","institution_ids":["https://openalex.org/I2800191616","https://openalex.org/I34352273"]},{"raw_affiliation_string":"Department of Clinical Pharmacy (P.-H.M.v.d.K.), Orbis Medical Centre, Sittard, the Netherlands","institution_ids":["https://openalex.org/I4210133559"]},{"raw_affiliation_string":"Hein A.W. van Onzenoort From the Department of Clinical Pharmacy (H.A.W.O.), Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands","institution_ids":["https://openalex.org/I2802934949"]},{"raw_affiliation_string":"Microlife Corporation (W.J.V.), Taipei, Taiwan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077975646","display_name":"Frederique E. Menger","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800191616","display_name":"Maastricht University Medical Centre","ror":"https://ror.org/02d9ce178","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2800191616"]},{"id":"https://openalex.org/I2802934949","display_name":"Radboud University Medical Center","ror":"https://ror.org/05wg1m734","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802934949"]},{"id":"https://openalex.org/I34352273","display_name":"Maastricht University","ror":"https://ror.org/02jz4aj89","country_code":"NL","type":"education","lineage":["https://openalex.org/I34352273"]},{"id":"https://openalex.org/I4210133559","display_name":"Zuyderland Medisch Centrum","ror":"https://ror.org/03bfc4534","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210133559","https://openalex.org/I4210166163"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Frederique E. Menger","raw_affiliation_strings":["From the Department of Clinical Pharmacy (H.A.W.O.), Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands; Utrecht Institute for Pharmaceutical Sciences (F.E.M.), Division of Pharmacoepidemiology and Pharmacotherapy, Utrecht, the Netherlands, Department of Clinical Pharmacy and Toxicology (C.N.), University Hospital Maastricht, Maastricht, the Netherlands; Cardiovascular Research Institute Maastricht (C.N., A.A.K., P.W.d.L.), Maastricht University and Department of Internal Medicine","Cardiovascular Research Institute Maastricht (C.N., A.A.K., P.W.d.L.), Maastricht University and Department of Internal Medicine, University Hospital Maastricht, Maastricht, the Netherlands","Department of Clinical Pharmacy (P.-H.M.v.d.K.), Orbis Medical Centre, Sittard, the Netherlands","Frederique E. Menger From the Department of Clinical Pharmacy (H.A.W.O.), Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands","Microlife Corporation (W.J.V.), Taipei, Taiwan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Clinical Pharmacy (H.A.W.O.), Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands; Utrecht Institute for Pharmaceutical Sciences (F.E.M.), Division of Pharmacoepidemiology and Pharmacotherapy, Utrecht, the Netherlands, Department of Clinical Pharmacy and Toxicology (C.N.), University Hospital Maastricht, Maastricht, the Netherlands; Cardiovascular Research Institute Maastricht (C.N., A.A.K., P.W.d.L.), Maastricht University and Department of Internal Medicine","institution_ids":["https://openalex.org/I2800191616","https://openalex.org/I2802934949","https://openalex.org/I34352273"]},{"raw_affiliation_string":"Cardiovascular Research Institute Maastricht (C.N., A.A.K., P.W.d.L.), Maastricht University and Department of Internal Medicine, University Hospital Maastricht, Maastricht, the Netherlands","institution_ids":["https://openalex.org/I2800191616","https://openalex.org/I34352273"]},{"raw_affiliation_string":"Department of Clinical Pharmacy (P.-H.M.v.d.K.), Orbis Medical Centre, Sittard, the Netherlands","institution_ids":["https://openalex.org/I4210133559"]},{"raw_affiliation_string":"Frederique E. Menger From the Department of Clinical Pharmacy (H.A.W.O.), Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands","institution_ids":["https://openalex.org/I2802934949"]},{"raw_affiliation_string":"Microlife Corporation (W.J.V.), Taipei, Taiwan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040069163","display_name":"Cees Neef","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800191616","display_name":"Maastricht University Medical Centre","ror":"https://ror.org/02d9ce178","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2800191616"]},{"id":"https://openalex.org/I2802934949","display_name":"Radboud University Medical Center","ror":"https://ror.org/05wg1m734","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802934949"]},{"id":"https://openalex.org/I34352273","display_name":"Maastricht University","ror":"https://ror.org/02jz4aj89","country_code":"NL","type":"education","lineage":["https://openalex.org/I34352273"]},{"id":"https://openalex.org/I4210133559","display_name":"Zuyderland Medisch Centrum","ror":"https://ror.org/03bfc4534","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210133559","https://openalex.org/I4210166163"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Cees Neef","raw_affiliation_strings":["From the Department of Clinical Pharmacy (H.A.W.O.), Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands; Utrecht Institute for Pharmaceutical Sciences (F.E.M.), Division of Pharmacoepidemiology and Pharmacotherapy, Utrecht, the Netherlands, Department of Clinical Pharmacy and Toxicology (C.N.), University Hospital Maastricht, Maastricht, the Netherlands; Cardiovascular Research Institute Maastricht (C.N., A.A.K., P.W.d.L.), Maastricht University and Department of Internal Medicine","Cardiovascular Research Institute Maastricht (C.N., A.A.K., P.W.d.L.), Maastricht University and Department of Internal Medicine, University Hospital Maastricht, Maastricht, the Netherlands","Cees Neef From the Department of Clinical Pharmacy (H.A.W.O.), Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands","Department of Clinical Pharmacy (P.-H.M.v.d.K.), Orbis Medical Centre, Sittard, the Netherlands","Microlife Corporation (W.J.V.), Taipei, Taiwan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Clinical Pharmacy (H.A.W.O.), Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands; Utrecht Institute for Pharmaceutical Sciences (F.E.M.), Division of Pharmacoepidemiology and Pharmacotherapy, Utrecht, the Netherlands, Department of Clinical Pharmacy and Toxicology (C.N.), University Hospital Maastricht, Maastricht, the Netherlands; Cardiovascular Research Institute Maastricht (C.N., A.A.K., P.W.d.L.), Maastricht University and Department of Internal Medicine","institution_ids":["https://openalex.org/I2800191616","https://openalex.org/I2802934949","https://openalex.org/I34352273"]},{"raw_affiliation_string":"Cardiovascular Research Institute Maastricht (C.N., A.A.K., P.W.d.L.), Maastricht University and Department of Internal Medicine, University Hospital Maastricht, Maastricht, the Netherlands","institution_ids":["https://openalex.org/I2800191616","https://openalex.org/I34352273"]},{"raw_affiliation_string":"Cees Neef From the Department of Clinical Pharmacy (H.A.W.O.), Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands","institution_ids":["https://openalex.org/I2802934949"]},{"raw_affiliation_string":"Department of Clinical Pharmacy (P.-H.M.v.d.K.), Orbis Medical Centre, Sittard, the Netherlands","institution_ids":["https://openalex.org/I4210133559"]},{"raw_affiliation_string":"Microlife Corporation (W.J.V.), Taipei, Taiwan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006643437","display_name":"Willem J. Verberk","orcid":"https://orcid.org/0000-0003-2230-0488","observed_orcids":["https://orcid.org/0000-0003-2230-0488"]},"institutions":[{"id":"https://openalex.org/I2800191616","display_name":"Maastricht University Medical Centre","ror":"https://ror.org/02d9ce178","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2800191616"]},{"id":"https://openalex.org/I2802934949","display_name":"Radboud University Medical Center","ror":"https://ror.org/05wg1m734","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802934949"]},{"id":"https://openalex.org/I34352273","display_name":"Maastricht University","ror":"https://ror.org/02jz4aj89","country_code":"NL","type":"education","lineage":["https://openalex.org/I34352273"]},{"id":"https://openalex.org/I4210133559","display_name":"Zuyderland Medisch Centrum","ror":"https://ror.org/03bfc4534","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210133559","https://openalex.org/I4210166163"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Willem J. Verberk","raw_affiliation_strings":["From the Department of Clinical Pharmacy (H.A.W.O.), Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands; Utrecht Institute for Pharmaceutical Sciences (F.E.M.), Division of Pharmacoepidemiology and Pharmacotherapy, Utrecht, the Netherlands, Department of Clinical Pharmacy and Toxicology (C.N.), University Hospital Maastricht, Maastricht, the Netherlands; Cardiovascular Research Institute Maastricht (C.N., A.A.K., P.W.d.L.), Maastricht University and Department of Internal Medicine","Cardiovascular Research Institute Maastricht (C.N., A.A.K., P.W.d.L.), Maastricht University and Department of Internal Medicine, University Hospital Maastricht, Maastricht, the Netherlands","Department of Clinical Pharmacy (P.-H.M.v.d.K.), Orbis Medical Centre, Sittard, the Netherlands","Microlife Corporation (W.J.V.), Taipei, Taiwan","Willem J. Verberk From the Department of Clinical Pharmacy (H.A.W.O.), Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Clinical Pharmacy (H.A.W.O.), Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands; Utrecht Institute for Pharmaceutical Sciences (F.E.M.), Division of Pharmacoepidemiology and Pharmacotherapy, Utrecht, the Netherlands, Department of Clinical Pharmacy and Toxicology (C.N.), University Hospital Maastricht, Maastricht, the Netherlands; Cardiovascular Research Institute Maastricht (C.N., A.A.K., P.W.d.L.), Maastricht University and Department of Internal Medicine","institution_ids":["https://openalex.org/I2800191616","https://openalex.org/I2802934949","https://openalex.org/I34352273"]},{"raw_affiliation_string":"Cardiovascular Research Institute Maastricht (C.N., A.A.K., P.W.d.L.), Maastricht University and Department of Internal Medicine, University Hospital Maastricht, Maastricht, the Netherlands","institution_ids":["https://openalex.org/I2800191616","https://openalex.org/I34352273"]},{"raw_affiliation_string":"Department of Clinical Pharmacy (P.-H.M.v.d.K.), Orbis Medical Centre, Sittard, the Netherlands","institution_ids":["https://openalex.org/I4210133559"]},{"raw_affiliation_string":"Microlife Corporation (W.J.V.), Taipei, Taiwan","institution_ids":[]},{"raw_affiliation_string":"Willem J. Verberk From the Department of Clinical Pharmacy (H.A.W.O.), Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands","institution_ids":["https://openalex.org/I2802934949"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060908850","display_name":"Abraham A. Kroon","orcid":"https://orcid.org/0000-0001-7750-8249","observed_orcids":["https://orcid.org/0000-0001-7750-8249"]},"institutions":[{"id":"https://openalex.org/I2800191616","display_name":"Maastricht University Medical Centre","ror":"https://ror.org/02d9ce178","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2800191616"]},{"id":"https://openalex.org/I2802934949","display_name":"Radboud University Medical Center","ror":"https://ror.org/05wg1m734","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802934949"]},{"id":"https://openalex.org/I34352273","display_name":"Maastricht University","ror":"https://ror.org/02jz4aj89","country_code":"NL","type":"education","lineage":["https://openalex.org/I34352273"]},{"id":"https://openalex.org/I4210133559","display_name":"Zuyderland Medisch Centrum","ror":"https://ror.org/03bfc4534","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210133559","https://openalex.org/I4210166163"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Abraham A. Kroon","raw_affiliation_strings":["From the Department of Clinical Pharmacy (H.A.W.O.), Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands; Utrecht Institute for Pharmaceutical Sciences (F.E.M.), Division of Pharmacoepidemiology and Pharmacotherapy, Utrecht, the Netherlands, Department of Clinical Pharmacy and Toxicology (C.N.), University Hospital Maastricht, Maastricht, the Netherlands; Cardiovascular Research Institute Maastricht (C.N., A.A.K., P.W.d.L.), Maastricht University and Department of Internal Medicine","Abraham A. Kroon From the Department of Clinical Pharmacy (H.A.W.O.), Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands","Cardiovascular Research Institute Maastricht (C.N., A.A.K., P.W.d.L.), Maastricht University and Department of Internal Medicine, University Hospital Maastricht, Maastricht, the Netherlands","Department of Clinical Pharmacy (P.-H.M.v.d.K.), Orbis Medical Centre, Sittard, the Netherlands","Microlife Corporation (W.J.V.), Taipei, Taiwan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Clinical Pharmacy (H.A.W.O.), Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands; Utrecht Institute for Pharmaceutical Sciences (F.E.M.), Division of Pharmacoepidemiology and Pharmacotherapy, Utrecht, the Netherlands, Department of Clinical Pharmacy and Toxicology (C.N.), University Hospital Maastricht, Maastricht, the Netherlands; Cardiovascular Research Institute Maastricht (C.N., A.A.K., P.W.d.L.), Maastricht University and Department of Internal Medicine","institution_ids":["https://openalex.org/I2800191616","https://openalex.org/I2802934949","https://openalex.org/I34352273"]},{"raw_affiliation_string":"Abraham A. Kroon From the Department of Clinical Pharmacy (H.A.W.O.), Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands","institution_ids":["https://openalex.org/I2802934949"]},{"raw_affiliation_string":"Cardiovascular Research Institute Maastricht (C.N., A.A.K., P.W.d.L.), Maastricht University and Department of Internal Medicine, University Hospital Maastricht, Maastricht, the Netherlands","institution_ids":["https://openalex.org/I2800191616","https://openalex.org/I34352273"]},{"raw_affiliation_string":"Department of Clinical Pharmacy (P.-H.M.v.d.K.), Orbis Medical Centre, Sittard, the Netherlands","institution_ids":["https://openalex.org/I4210133559"]},{"raw_affiliation_string":"Microlife Corporation (W.J.V.), Taipei, Taiwan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006873737","display_name":"Peter W. de Leeuw","orcid":"https://orcid.org/0000-0002-4949-5812","observed_orcids":["https://orcid.org/0000-0002-4949-5812"]},"institutions":[{"id":"https://openalex.org/I2800191616","display_name":"Maastricht University Medical Centre","ror":"https://ror.org/02d9ce178","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2800191616"]},{"id":"https://openalex.org/I2802934949","display_name":"Radboud University Medical Center","ror":"https://ror.org/05wg1m734","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802934949"]},{"id":"https://openalex.org/I34352273","display_name":"Maastricht University","ror":"https://ror.org/02jz4aj89","country_code":"NL","type":"education","lineage":["https://openalex.org/I34352273"]},{"id":"https://openalex.org/I4210133559","display_name":"Zuyderland Medisch Centrum","ror":"https://ror.org/03bfc4534","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210133559","https://openalex.org/I4210166163"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Peter W. de Leeuw","raw_affiliation_strings":["From the Department of Clinical Pharmacy (H.A.W.O.), Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands; Utrecht Institute for Pharmaceutical Sciences (F.E.M.), Division of Pharmacoepidemiology and Pharmacotherapy, Utrecht, the Netherlands, Department of Clinical Pharmacy and Toxicology (C.N.), University Hospital Maastricht, Maastricht, the Netherlands; Cardiovascular Research Institute Maastricht (C.N., A.A.K., P.W.d.L.), Maastricht University and Department of Internal Medicine","Cardiovascular Research Institute Maastricht (C.N., A.A.K., P.W.d.L.), Maastricht University and Department of Internal Medicine, University Hospital Maastricht, Maastricht, the Netherlands","Department of Clinical Pharmacy (P.-H.M.v.d.K.), Orbis Medical Centre, Sittard, the Netherlands","Microlife Corporation (W.J.V.), Taipei, Taiwan","Peter W. de Leeuw From the Department of Clinical Pharmacy (H.A.W.O.), Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Clinical Pharmacy (H.A.W.O.), Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands; Utrecht Institute for Pharmaceutical Sciences (F.E.M.), Division of Pharmacoepidemiology and Pharmacotherapy, Utrecht, the Netherlands, Department of Clinical Pharmacy and Toxicology (C.N.), University Hospital Maastricht, Maastricht, the Netherlands; Cardiovascular Research Institute Maastricht (C.N., A.A.K., P.W.d.L.), Maastricht University and Department of Internal Medicine","institution_ids":["https://openalex.org/I2800191616","https://openalex.org/I2802934949","https://openalex.org/I34352273"]},{"raw_affiliation_string":"Cardiovascular Research Institute Maastricht (C.N., A.A.K., P.W.d.L.), Maastricht University and Department of Internal Medicine, University Hospital Maastricht, Maastricht, the Netherlands","institution_ids":["https://openalex.org/I2800191616","https://openalex.org/I34352273"]},{"raw_affiliation_string":"Department of Clinical Pharmacy (P.-H.M.v.d.K.), Orbis Medical Centre, Sittard, the Netherlands","institution_ids":["https://openalex.org/I4210133559"]},{"raw_affiliation_string":"Microlife Corporation (W.J.V.), Taipei, Taiwan","institution_ids":[]},{"raw_affiliation_string":"Peter W. de Leeuw From the Department of Clinical Pharmacy (H.A.W.O.), Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands","institution_ids":["https://openalex.org/I2802934949"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5051307639","display_name":"P.H.M. van der Kuy","orcid":"https://orcid.org/0000-0002-7128-8801","observed_orcids":["https://orcid.org/0000-0002-7128-8801"]},"institutions":[{"id":"https://openalex.org/I2800191616","display_name":"Maastricht University Medical Centre","ror":"https://ror.org/02d9ce178","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2800191616"]},{"id":"https://openalex.org/I2802934949","display_name":"Radboud University Medical Center","ror":"https://ror.org/05wg1m734","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802934949"]},{"id":"https://openalex.org/I34352273","display_name":"Maastricht University","ror":"https://ror.org/02jz4aj89","country_code":"NL","type":"education","lineage":["https://openalex.org/I34352273"]},{"id":"https://openalex.org/I4210133559","display_name":"Zuyderland Medisch Centrum","ror":"https://ror.org/03bfc4534","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210133559","https://openalex.org/I4210166163"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Paul-Hugo M. van der Kuy","raw_affiliation_strings":["From the Department of Clinical Pharmacy (H.A.W.O.), Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands; Utrecht Institute for Pharmaceutical Sciences (F.E.M.), Division of Pharmacoepidemiology and Pharmacotherapy, Utrecht, the Netherlands, Department of Clinical Pharmacy and Toxicology (C.N.), University Hospital Maastricht, Maastricht, the Netherlands; Cardiovascular Research Institute Maastricht (C.N., A.A.K., P.W.d.L.), Maastricht University and Department of Internal Medicine","Cardiovascular Research Institute Maastricht (C.N., A.A.K., P.W.d.L.), Maastricht University and Department of Internal Medicine, University Hospital Maastricht, Maastricht, the Netherlands","Department of Clinical Pharmacy (P.-H.M.v.d.K.), Orbis Medical Centre, Sittard, the Netherlands","Microlife Corporation (W.J.V.), Taipei, Taiwan","Paul-Hugo M. van der Kuy From the Department of Clinical Pharmacy (H.A.W.O.), Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Department of Clinical Pharmacy (H.A.W.O.), Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands; Utrecht Institute for Pharmaceutical Sciences (F.E.M.), Division of Pharmacoepidemiology and Pharmacotherapy, Utrecht, the Netherlands, Department of Clinical Pharmacy and Toxicology (C.N.), University Hospital Maastricht, Maastricht, the Netherlands; Cardiovascular Research Institute Maastricht (C.N., A.A.K., P.W.d.L.), Maastricht University and Department of Internal Medicine","institution_ids":["https://openalex.org/I2800191616","https://openalex.org/I2802934949","https://openalex.org/I34352273"]},{"raw_affiliation_string":"Cardiovascular Research Institute Maastricht (C.N., A.A.K., P.W.d.L.), Maastricht University and Department of Internal Medicine, University Hospital Maastricht, Maastricht, the Netherlands","institution_ids":["https://openalex.org/I2800191616","https://openalex.org/I34352273"]},{"raw_affiliation_string":"Department of Clinical Pharmacy (P.-H.M.v.d.K.), Orbis Medical Centre, Sittard, the Netherlands","institution_ids":["https://openalex.org/I4210133559"]},{"raw_affiliation_string":"Microlife Corporation (W.J.V.), Taipei, Taiwan","institution_ids":[]},{"raw_affiliation_string":"Paul-Hugo M. van der Kuy From the Department of Clinical Pharmacy (H.A.W.O.), Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands","institution_ids":["https://openalex.org/I2802934949"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5049645213"],"corresponding_institution_ids":["https://openalex.org/I2800191616","https://openalex.org/I2802934949","https://openalex.org/I34352273","https://openalex.org/I4210133559"],"apc_list":null,"apc_paid":null,"fwci":4.8313,"has_fulltext":true,"cited_by_count":157,"citation_normalized_percentile":{"value":0.94517314,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":100},"biblio":{"volume":"58","issue":"4","first_page":"573","last_page":"578"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11620","display_name":"Medication Adherence and Compliance","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2714","display_name":"Family Practice"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11620","display_name":"Medication Adherence and Compliance","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2714","display_name":"Family Practice"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10582","display_name":"Ethics in Clinical Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/clinical-trial-participation","display_name":"clinical trial participation","score":0.9269999861717224},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.9279999732971191},{"id":"https://openalex.org/keywords/medication-persistence","display_name":"treatment persistence","score":0.8709999918937683},{"id":"https://openalex.org/keywords/pharmacy-refill-data","display_name":"pharmacy refill data","score":0.7870000004768372},{"id":"https://openalex.org/keywords/antihypertensive-drugs","display_name":"antihypertensive drugs","score":0.6949999928474426},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.7450000047683716}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.886640191078186},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.752386212348938},{"id":"https://openalex.org/C2781009140","wikidata":"https://www.wikidata.org/wiki/Q7170389","display_name":"Persistence (discontinuity)","level":2,"score":0.7304361462593079},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.613234281539917},{"id":"https://openalex.org/C104863432","wikidata":"https://www.wikidata.org/wiki/Q614304","display_name":"Pharmacy","level":2,"score":0.5771225690841675},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5577257871627808},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.55503249168396},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.5265420079231262},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.48857149481773376},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.34002986550331116},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.1206677258014679},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.09371539950370789},{"id":"https://openalex.org/C187320778","wikidata":"https://www.wikidata.org/wiki/Q1349130","display_name":"Geotechnical engineering","level":1,"score":0.0},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009042","descriptor_name":"Motivation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D010349","descriptor_name":"Patient Compliance","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":true},{"descriptor_ui":"D010349","descriptor_name":"Patient Compliance","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D010358","descriptor_name":"Patient Participation","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":true},{"descriptor_ui":"D010358","descriptor_name":"Patient Participation","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D011307","descriptor_name":"Drug Prescriptions","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.1161/hypertensionaha.111.171074","doi":"https://doi.org/10.1161/hypertensionaha.111.171074","is_oa":true,"landing_page_url":"https://doi.org/10.1161/hypertensionaha.111.171074","pdf_url":"https://www.ahajournals.org/doi/pdf/10.1161/HYPERTENSIONAHA.111.171074","source":{"id":"https://openalex.org/S67880631","display_name":"Hypertension","issn_l":"0194-911X","issn":["0194-911X","1524-4563"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hypertension","raw_type":"journal-article"},{"id":"pmid:21825228","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21825228","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hypertension (Dallas, Tex. : 1979)","raw_type":"Comparative Study"},{"id":"pmh:oai:cris.maastrichtuniversity.nl:openaire/b0f34b4e-cd42-48c1-a2ee-7a268ca0785b","doi":null,"is_oa":true,"landing_page_url":"https://cris.maastrichtuniversity.nl/en/publications/b0f34b4e-cd42-48c1-a2ee-7a268ca0785b","pdf_url":null,"source":{"id":"https://openalex.org/S4306402616","display_name":"Research Publications (Maastricht University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I34352273","host_organization_name":"Maastricht University","host_organization_lineage":["https://openalex.org/I34352273"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"van Onzenoort, H A W, Menger, F E, Neef, C, Verberk, W J, Kroon, A A, de Leeuw, P W & van der Kuy, P-H M 2011, 'Participation in a Clinical Trial Enhances Adherence and Persistence to Treatment A Retrospective Cohort Study', Hypertension, vol. 58, no. 4, pp. 573-578. https://doi.org/10.1161/HYPERTENSIONAHA.111.171074","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:pure.eur.nl:openaire_cris_publications/538e2614-a766-4c10-a656-f46371378a61","doi":null,"is_oa":false,"landing_page_url":"https://pure.eur.nl/en/publications/538e2614-a766-4c10-a656-f46371378a61","pdf_url":null,"source":{"id":"https://openalex.org/S4306401266","display_name":"EUR Research Repository (Erasmus University Rotterdam)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I913958620","host_organization_name":"Erasmus University Rotterdam","host_organization_lineage":["https://openalex.org/I913958620"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Van Onzenoort, H A W, Menger, F E, Neef, C, Verberk, W J, Kroon, A A, De Leeuw, P W & Van Der Kuy, P H M 2011, 'Participation in a clinical trial enhances adherence and persistence to treatment : A retrospective cohort study', Hypertension, vol. 58, no. 4, pp. 573-578. https://doi.org/10.1161/HYPERTENSIONAHA.111.171074","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:repository.ubn.ru.nl:2066/97202","doi":null,"is_oa":false,"landing_page_url":"https://hdl.handle.net/2066/97202","pdf_url":null,"source":{"id":"https://openalex.org/S4306401067","display_name":"Radboud Repository (Radboud University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I145872427","host_organization_name":"Radboud University Nijmegen","host_organization_lineage":["https://openalex.org/I145872427"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Article / Letter to editor"},{"id":"pmh:um:oai:cris.maastrichtuniversity.nl:publications/b0f34b4e-cd42-48c1-a2ee-7a268ca0785b","doi":null,"is_oa":true,"landing_page_url":"https://cris.maastrichtuniversity.nl/en/publications/b0f34b4e-cd42-48c1-a2ee-7a268ca0785b","pdf_url":null,"source":{"id":"https://openalex.org/S4306402616","display_name":"Research Publications (Maastricht University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I34352273","host_organization_name":"Maastricht University","host_organization_lineage":["https://openalex.org/I34352273"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Hypertension, 58(4), 573 - 578. LIPPINCOTT WILLIAMS &amp; WILKINS","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1161/hypertensionaha.111.171074","doi":"https://doi.org/10.1161/hypertensionaha.111.171074","is_oa":true,"landing_page_url":"https://doi.org/10.1161/hypertensionaha.111.171074","pdf_url":"https://www.ahajournals.org/doi/pdf/10.1161/HYPERTENSIONAHA.111.171074","source":{"id":"https://openalex.org/S67880631","display_name":"Hypertension","issn_l":"0194-911X","issn":["0194-911X","1524-4563"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hypertension","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2116239162.pdf","grobid_xml":"https://content.openalex.org/works/W2116239162.grobid-xml"},"referenced_works_count":27,"referenced_works":["https://openalex.org/W1845225129","https://openalex.org/W1972110417","https://openalex.org/W1976266826","https://openalex.org/W1980533403","https://openalex.org/W1988517264","https://openalex.org/W1996806453","https://openalex.org/W1997641519","https://openalex.org/W2016503459","https://openalex.org/W2054956235","https://openalex.org/W2057112394","https://openalex.org/W2058749856","https://openalex.org/W2063844762","https://openalex.org/W2085066808","https://openalex.org/W2106167834","https://openalex.org/W2111179294","https://openalex.org/W2132278229","https://openalex.org/W2141584391","https://openalex.org/W2160570666","https://openalex.org/W2161863423","https://openalex.org/W2313754305","https://openalex.org/W2318545861","https://openalex.org/W2322116503","https://openalex.org/W2395724646","https://openalex.org/W2397791882","https://openalex.org/W2442086988","https://openalex.org/W2442856728","https://openalex.org/W7014457622"],"related_works":["https://openalex.org/W2070715968","https://openalex.org/W7140063824","https://openalex.org/W2410068606","https://openalex.org/W2617454018","https://openalex.org/W2144550281","https://openalex.org/W4379058204","https://openalex.org/W2126796184","https://openalex.org/W2340291386","https://openalex.org/W2417486656"],"abstract_inverted_index":{"Poor":[0],"adherence":[1,23,31,93,146,158,168,172,230],"to":[2,24,29,94,108,138,149,169,173,186,208,221,231],"treatment":[3,95,210],"is":[4],"one":[5],"of":[6,10,62,78,117,162,181,191],"the":[7,57,70,99,113,118,130,142,157,160,163,192],"major":[8],"determinants":[9],"an":[11],"uncontrolled":[12],"blood":[13],"pressure.":[14],"Participation":[15,128,223],"in":[16,35,42,56,69,224,240],"a":[17,43,179,225,241],"clinical":[18,44,226],"trial":[19,131,143,164,170,182,227,242],"may":[20],"increase":[21],"patient's":[22],"treatment.":[25],"This":[26],"prompted":[27],"us":[28],"investigate":[30],"and":[32,53,84,103,234,249],"persistence":[33,195],"profiles":[34],"patients":[36,64],"with":[37,65,212,246],"hypertension":[38,66],"who":[39,67],"had":[40],"participated":[41,68],"trial,":[45,193],"by":[46],"collecting":[47],"pharmacy":[48],"refill":[49,60,134,145],"data":[50,61,121],"before,":[51,101],"during,":[52,102],"after":[54,104,115],"participation":[55],"trial.":[58,106,119],"Pharmacy":[59],"182":[63],"Home":[71],"Versus":[72],"Office":[73],"Blood":[74],"Pressure":[75],"Measurements:":[76],"Reduction":[77],"Unnecessary":[79],"Treatment":[80],"Study":[81],"between":[82],"2001":[83],"2005":[85],"were":[86,122,205],"obtained":[87],"from":[88,136,156,184],"1999":[89],"until":[90],"2010.":[91],"Refill":[92,120],"was":[96,110,196],"compared":[97,211],"for":[98,112,124,167],"periods":[100],"this":[105],"Persistence":[107],"medication":[109],"investigated":[111],"period":[114],"termination":[116,190],"available":[123],"22":[125],"600":[126],"prescriptions.":[127],"into":[129],"significantly":[132,228],"increased":[133,177],"adherence,":[135],"90.6%":[137],"95.6%":[139],"(P<0.001).":[140,188],"After":[141,189],"period,":[144],"decreased":[147],"again":[148],"91.8%":[150],"(P<0.001),":[151],"which":[152],"did":[153],"not":[154],"differ":[155],"before":[159],"start":[161],"(P=0.45).":[165],"Except":[166],"medication,":[171],"nontrial-related":[174,235],"drugs":[175],"also":[176],"as":[178,201],"consequence":[180],"participation,":[183],"77.6%":[185],"89.6%":[187],"median":[194],"1424":[197],"days.":[198],"Participants":[199],"classified":[200],"adherent":[202],"(adherence:":[203],">90%)":[204],"less":[206],"likely":[207],"discontinue":[209],"nonadherent":[213],"participants":[214,239],"(odds":[215],"ratio:":[216],"0.66":[217],"[95%":[218],"CI:":[219],"0.45":[220],"0.98]).":[222],"increases":[229],"both":[232],"trial-related":[233],"treatment,":[236],"suggesting":[237],"that":[238],"are":[243],"more":[244],"involved":[245],"their":[247],"conditions":[248],"treatments.":[250]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2116239162","counts_by_year":[{"year":2026,"cited_by_count":8},{"year":2025,"cited_by_count":15},{"year":2024,"cited_by_count":12},{"year":2023,"cited_by_count":20},{"year":2022,"cited_by_count":14},{"year":2021,"cited_by_count":11},{"year":2020,"cited_by_count":9},{"year":2019,"cited_by_count":18},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":12},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2016-06-24T00:00:00"}
